Congestion and sleep impairment in allergic rhinitis

Asian Pacific Journal of Allergy and Immunology

Volumn 29, Issue 4, 2011, Pages 297-306

  Sardana, Niti ^a   Craig, Timothy J ^b  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Allergic rhinitis; Daytime somnolence; Quality of life; Sleep

Indexed keywords

ANTIHISTAMINIC AGENT; AZELASTINE; BECLOMETASONE DIPROPIONATE; BRADYKININ; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DECONGESTIVE AGENT; FLUNISOLIDE; FLUTICASONE PROPIONATE; HISTAMINE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; IPRATROPIUM BROMIDE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; PLACEBO; SUBSTANCE P; TRIAMCINOLONE ACETONIDE; TUMOR NECROSIS FACTOR;

ALLERGIC RHINITIS; ARTICLE; CORTICOSTEROID THERAPY; CYTOKINE RELEASE; DAYTIME SOMNOLENCE; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; EYE DISEASE; FATIGUE; HUMAN; NEUROPATHOLOGY; NOSE CONGESTION; PATHOPHYSIOLOGY; PRODUCTIVITY; QUALITY OF LIFE; RHINORRHEA; SLEEP APNEA SYNDROME; SLEEP DISORDER; SLEEP QUALITY; SOMNOLENCE; TACHYCARDIA; URINE RETENTION;

ADULT; ANTI-ALLERGIC AGENTS; CHILD; FEMALE; HUMANS; MALE; QUALITY OF LIFE; RHINITIS, ALLERGIC, PERENNIAL; SLEEP; SLEEP DISORDERS;

EID: 84855251937     PISSN: 0125877X     EISSN: 22288694     Source Type: Journal    
DOI: None     Document Type: Article

References (76)

1. Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J. 2004;4:758-64.
2. Derebery J, Meltzer E, Nathan RA, Stang PE, Campbell UB, Corrao M, et al. Rhinitis symptoms and comorbidities in the United States: Burden of Rhinitis in America survey. Otolaryngol Head Neck Surg.2008;139:198-205.
3. Rappai M, Collop N, Kemp S. The nose and sleep-disordered breathing. What we know and what we do not know. Chest. 2003;124:2309-23.
4. Meltzer EO, Blaiss MS, Derebery MJ, Mahr TA, Gordon BR, Sheth KK, et al. Burden of allergic rhinitis: results from the Pediatric Allergies in America survey. J Allergy Clin Immunol. 2009;124:S43-70.
5. Meltzer EO, Nathan R, Derebery J, Stang PE, Campbell UB, Yeh WS, et al. Sleep, quality of life, and productivity impact of nasal symptoms in the United States: findings from the Burden of Rhinitis in America survey. Allergy Asthma Proc. 2009;30:244-54.
6. Blaiss M, Reigel T, Philpot E. A study to determine the impact of rhinitis on sufferers' sleep and daily routine [unpublished observations]. J Allergy Clin Immunol. 2005;115:S197.
7. Stempel DA, Woolf R. The cost of treating allergic rhinitis. Curr Allergy Asthma Rep. 2002;2:223-30.
8. Leynaert B, Neukirch C, Liard R. Quality of life in allergic rhinitis and asthma. A population-based study of young adults. Am J Respir Crit Care Med. 2000;162:1391-6.
9. Meltzer EO. Quality of life in adults and children with allergic rhinitis. J Allergy Clin Immunol. 2001;108:S45-53.
10. Stull DE, Roberts L, Frank L, Heithoff K. Relationship of nasal congestion with sleep, mood, and productivity. Curr Med Res Opin. 2007;23:811-9.
11. McNicholas WT, Tarlo S, Cole P, Zamel N, Rutherford R, Griffin D, et al. Obstructive sleep apneas during sleep in patients with seasonal allergic rhinitis. Am Rev Respir Dis. 1982;126:625-8.
12. Staevska MT, Mandajieva MA, Dimitrov VD. Rhinitis and sleep apnea. Curr Allergy Asthma Rep. 2004;4:193-9.
13. Lavie P, Gertner R, Zomer J, Podoshin L. Breathing disorders in sleep associated with "microarousals" in patients with allergic rhinitis. Acta Otolaryngol. 1981;92:529-33.
14. Kramer MF, De La Chaux R, Derher A, Pfrogner E, Rasp G, Allergic rhinitis does not constitute a risk factor for obstructive sleep apnea syndrome. Acta Otolaryngol. 2001;121:494-9.
15. Young T, Finn L, Kim H. The University of Wisconsin Sleep and Respiratory Research Group: Nasal obstruction as a risk factor for sleep-disordered breathing. J Allergy Clin Immunol. 1997;99:S757-62.
16. Rimmer J, Downie S, Bartlett DJ, Gralton JS, alome C. Sleep disturbance in persistent allergic rhinitis measured using actigraphy. Ann Allergy Asthma Immunol. 2009;103:190-4.
17. Sogut A, Altin R, Uzun L, Ugur MB, Tomac N, Acun C, et al. Prevalence of obstructive sleep apnea syndrome and associated symptoms in 3-11 year-old Turkish children. Pediatr Pulmonol. 2005;39:251-6.
18. Bixler EO, Vgontzas AN, Lin HM, Liao D, Calhoun S, Vela-Bueno A, et al. Sleep disordered breathing in children in a general population sample: prevalence and risk factors. Sleep. 2009;32:731-6.
19. Janson C, De Backer W, Gislason T, Plaschke P, Björnsson E, Hetta J, et al. Increased prevalence of sleep disturbances and daytime sleepiness in subjects with bronchial asthma: a population study of young adults in three European countries. Eur Respir J. 1996;9:2132-8.
20. Craig TJ, McCann JL, Gurevich F, Davies MJ. The correlation between allergic rhinitis and sleep disturbance. J Allergy Clin Immunol. 2004;114:S139-45.
21. Craig TJ, Teets S, Lehman EB, Chinchilli VM, Zwillich C. Nasal congestion secondary to allergic rhinitis as a cause of sleep disturbance and daytime fatigue and the response to topical nasal corticosteroids. J Allergy Clin Immunol. 1998;101:633-7.
22. Stuck BA, Czajkowski J, Hagner AE, Klimek L, Verse T, Hörmann K, et al. Changes in daytime sleepiness, quality of life, and objective sleep patterns in seasonal allergic rhinitis: a controlled clinical trial. J Allergy Clin Immunol. 2004;113:663-8.
23. Corey JP, Houser SM, Ng BA. Nasal congestion: a review of its etiology, evaluation, and treatment. Ear Nose Throat J. 2000;79:690-8.
24. Nathan RA, Eccles R, Howarth PH, Steinsvag SK, Togias A. Objective monitoring of nasal patency and nasal physiology in rhinitis. J Allergy Clin Immunol. 2005;115:S442-59.
25. Rundcrantz H. Postural variations of nasal patency. Acta Otolaryngol 1969. 68:435-43.
26. Landstra AM, Postma DS, Boezen HM, van Aalderen WM. Role of serum cortisol levels in children with asthma. Am J Respir Crit Care Med. 2002;165:708-12.
27. Reinberg A, Gervais P, Levi F, Smolensky M, Del Cerro L, Ugolini C. Circadian and circannual rhythms of allergic rhinitis: an epidemiologic study involving chronobiologic methods. J Allergy Clin Immunol. 1988;81:51-62.
28. Impact of Nasal Congestion Among Allergic Rhinitis Sufferers. An Internet Survey of 2002 People. New York: Roper Public Affairs Group of NOP World. 2004.
29. Juniper EF, Rohrbaugh T, Meltzer EO. A questionnaire to measure quality of life in adults with nocturnal allergic rhinoconjunctivitis. J Allergy Clin Immunol. 2003;111:484-90.
30. Canova CR, Downs SH, Knoblauch A, Andersson M, Tamm M, Leuppi JD. Increased prevalence of perennial allergic rhinitis in patients with obstructive sleep apnea. Respiration. 2004;71:138-43.
31. Young T, Finn L, Palta M Chronic nasal congestion at night is a risk factor for snoring in a population-based cohort study. Arch Intern Med. 2001;161:1514-9.
32. Pitt AD, Smith AF, Lindsell L, Voon LW, Rose PW, Bron AJ. Economic and quality-of-life impact of seasonal allergic conjunctivitis in Oxfordshire. Ophthalmic Epidemiol. 2004;11:17-33.
33. Sack R, Conradi L, Beaton A, Sathe S, McNamara N, Leonardi A. Antibody array characterization of inflammatory mediators in allergic and normal tears in the open and closed eye environments. Exp Eye Res. 2007;85:528-38.
34. Tashiro M, Mochizuki H, Iwabuchi K, Sakurada Y, Itoh M, Watanabe T, et al. Roles of histamine in regulation of arousal and cognition: functional neuroimaging of histamine H1 receptors in human brain. Life Sci. 2002;72:409-14.
35. Mullington JM, Hinze-Selch D, Pollmacher T. Mediators of inflammation and their interaction with sleep: relevance for chronic fatigue syndrome and related conditions. Ann N Y Acad Sci. 2001;933:201-10.
36. Krouse HJ, Davis JE, Krouse JH. Immune mediators in allergic rhinitis and sleep. Otolaryngol Head Neck Surg. 2002;126:607-13.
37. Aoyagi M, Watanabe H, Sekine K, Nishimuta T, Konno A, Shimojo N, et al. Circadian variation in nasal reactivity in children with allergic rhinitis: correlation with the activity of eosinophils and basophilic cells. Int Arch Allergy Immunol. 1999;120:95-9.
38. Vgontzas AN, Zoumakis E, Bixler EO, Lin HM, Follett H, Kales A, et al. Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J Clin Endocrinol Metab. 2004;89:2119-26.
39. Woodson BT, Brusky LT, Saurajen A, Jaradeh S. Association of autonomic dysfunction and mild obstructive sleep apnea. Otolaryngol Head Neck Surg. 2004;130:643-8.
40. Marshall PS, O'Hara C, Steinberg P. Effects of seasonal allergic rhinitis on selected cognitive abilities. Ann Allergy Asthma Immunol. 2000;84:403-10.
41. Wilken JA, Berkowitz R, Kane R. Decrements in vigilance and cognitive functioning associated with ragweed-induced allergic rhinitis. Ann Allergy Asthma Immunol. 2002;89:372-80.
42. Kessler RC, Almeida DM, Berglund P, Stang P. Pollen and mold exposure impairs the work performance of employees with allergic rhinitis. Ann Allergy Asthma Immunol. 2001;87:289-95.
43. Lack G. Pediatric allergic rhinitis and comorbid disorders. J Allergy Clin Immunol. 2001;108:S9-15.
44. Simons FE. Learning impairment and allergic rhinitis. Allergy Asthma Proc. 1996;17.185-9.
45. Flemons WW, Tsai W. Quality of life consequences of sleep-disordered breathing. J Allergy Clin Immunol. 1997;99:S750-6.
46. Martin SE, Engleman HM, Deary IJ, Douglas NJ. The effect of sleep fragmentation on daytime function. Am J Respir Crit Care Med. 1996;153:1328-32.
47. Martin SE, Wraith PK, Deary IJ, Douglas NJ. The effect of nonvisible sleep fragmentation on daytime function. Am J Respir Crit Care Med. 1997;155:1596-601.
48. Juniper EF, Guyatt GH, Dolovich J. Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials. J Allergy Clin Immunol. 1994;93:413-23.
49. Fisher L, Ghaffari G, Davies M, Craig T. Effects of poor sleep in allergic rhinitis. Curr Opin Allergy Clin Immunol. 2005;5:11-6.
50. Kremer B, den Hartog HM, Jolles J. Relationship between allergic rhinitis, disturbed cognitive functions and psychological well-being. Clin Exp Allergy. 2002;32:1310-5.
51. Juniper EF, Stahl E, Doty RL, Simons FE, Allen DB, Howarth PH. Clinical outcomes and adverse effect monitoring in allergic rhinitis. J Allergy Clin Immunol. 2005;115:S390-413.
52. Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep. 1991;14:540-5.
53. Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989, 28.193-213.
54. Flemons WW, Reimer MA. Measurement properties of the Calgary Sleep Apnea Quality of Life Index. Am J Respir Crit Care Med. 2002;165:159-64.
55. Weaver TE, Laizner AM, Evans LK, Maislin G, Chugh DK, Lyon K, et al. An instrument to measure functional status outcomes for disorders of excessive sleepiness. Sleep. 1997;20:835-43.
56. Mansfield LE, Diaz G, Posey CR, Flores-Neder J. Sleep disordered breathing and daytime quality of life in children with allergic rhinitis during treatment with intranasal budesonide. Ann Allergy Asthma Immunol. 2004;92:240-4.
57. Craig TJ, Mende C, Hughes K, Kakumanu S, Lehman EB, Chinchilli V. The effect of topical nasal fluticasone on objective sleep testing and the symptoms of rhinitis, sleep, and daytime somnolence in perennial allergic rhinitis. Allergy Asthma Proc. 2003;24:53-8.
58. Murray JJ, Nathan RA, Bronsky EA, Olufade AO, Chapman D, Kramer B. Comprehensive evaluation of cetirizine in the management of seasonal allergic rhinitis: impact on symptoms, quality of life, productivity, and activity impairment. Allergy Asthma Proc. 2002; 23:391-8.
59. Golden S, Teets SJ, Lehman EB, Mauger EA, Chinchilli V, Berlin JM, et al. Effect of topical nasal azelastine on the symptoms of rhinitis, sleep, and daytime somnolence in perennial allergic rhinitis. Ann Allergy Asthma Immunol. 2000;85:53-7.
60. McLean HA, Urton AM, Driver HS, Tan AK, Day AG, Munt PW, et al. Effect of treating severe nasal obstruction on the severity of obstructive sleep apnea. Eur Respir J. 2005;25:521-7.
61. Milgrom H, Biondi R, Georgitis JW, Meltzer EO, Munk ZM, Drda K, et al. Comparison of ipratropium bromide 0.03% with beclomethasone dipropionate in the treatment of perennial rhinitis in children. Ann Allergy Asthma Immunol. 1999;83:105-11.
62. Goldbart AD, Goldman JL, Veling MC, Gozal D. Leukotriene modifier therapy for mild sleep-disordered breathing in children. Am J Respir Crit Care Med. 2005;172:364-70.
63. Moinuddin R, deTineo M, Maleckar B, Naclerio RM, Baroody FM. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2004;92:73-9.
64. Santos CB, Hanks C, McCann J, Lehman EB, Pratt E, Craig TJ. The role of montelukast on perennial allergic rhinitis and associated sleep disturbances and daytime somnolence. Allergy Asthma Proc.2008;29:140-5.
65. Bousquet J, van Cauwenberge P, Khaltaev N. ARIA Workshop Group, World Health Organization: Allergic rhinitis and its impact on asthma (ARIA). J Allergy Clin Immunol. 2001;108:S147-334.
66. Bende M, Carrillo T, Vóna I, da Castel-Branco MG, Arheden L. A randomized comparison of the effects of budesonide and mometasone furoate aqueous nasal sprays on nasal peak flow rate and symptoms in perennial allergic rhinitis. Ann Allergy Asthma Immunol. 2002;88:617-23.
67. Hughes K, Glass C, Ripchinski M, Gurevich F, Weaver TE, Lehman E, et al. Efficacy of the topical nasal steroid budesonide on improving sleep and daytime somnolence in patients with perennial allergic rhinitis. Allergy. 2003;58:380-5.
68. Craig TJ, Gurevich F, Glass C, Wei W, Lehman E. The effect of intranasal steroid budesonide on sleep disturbance and daytime somnolence in patients with perennial allergic rhinitis [abstract 1227]. J Allergy Clin Immunol. 2004;113:S332.
69. Berlin JM, Golden SJ, Teets S, Lehman EB, Lucas T, Craig TJ, Efficacy of a steroid nasal spray compared with an antihistamine nasal spray in the treatment of perennial allergic rhinitis. J Am Osteopath Assoc. 2000;100:8-13.
70. Mansfield LE, Posey CR. Daytime sleepiness and cognitive performance improve in seasonal allergic rhinitis treated with intranasal fluticasone propionate. Allergy Asthma Proc. 2007;28:226-9.
71. Bender BG, Milgrom H. Comparison of the effects of fluticasone propionate aqueous nasal spray and loratadine on daytime alertness and performance in children with seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2004;92:344-9.
72. Kiely JL, Nolan P, McNicholas WT. Intranasal corticosteroid therapy for obstructive sleep apnoea in patients with co-existing rhinitis. Thorax. 2004;59:50-5.
73. Potter PC, Van Niekerk CH, Schoeman HS. Effects of triamcinolone on quality of life in patients with persistent allergic rhinitis. Ann Allergy Asthma Immunol. 2003;91:368-74.
74. Mintz M, Garcia J, Diener P, Liao Y, Dupclay L, Georges G, Triamcinolone acetonide aqueous nasal spray improves nocturnal rhinitis-related quality of life in patients treated in a primary care setting: the Quality of Sleep in Allergic Rhinitis study. Ann Allergy Asthma Immunol. 2004;92:255-61.
75. Craig TJ, Ferguson BJ, Krouse JH. Sleep impairment in allergic rhinitis, rhinosinusitis, and nasal polyposis. Am J Otolaryngol. 2008;29:209-17.
76. Craig TJ, Sherkat A., Safee S. Congestion and Sleep Impairment in Allergic Rhinitis. Curr Allergy Asthma Rep. 2010; 10: 113-21.